Projects per year
Fingerprint
Dive into the research topics where Paul F. Riska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
MYCOBACTERIOPHANGE INTERACTION WITH M TUBERCULOSIS
Riska, P. F. (PI)
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
7/15/98 → 6/30/04
Project: Research project
-
MYCOBACTERIOPHANGE INTERACTION WITH M TUBERCULOSIS
Riska, P. F. (PI)
7/15/98 → 6/30/04
Project: Research project
-
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group & ACTT-3 Study Group, Mar 2024, In: EClinicalMedicine. 69, 102472.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
Singh, K., Rubenstein, K., Callier, V., Shaw-Saliba, K., Rupert, A., Dewar, R., Laverdure, S., Highbarger, H., Lallemand, P., Huang, M. L., Jerome, K. R., Sampoleo, R., Mills, M. G., Greninger, A. L., Juneja, K., Porter, D., Benson, C. A., Dempsey, W., El Sahly, H. M. & Focht, C. & 187 others, , Sep 15 2024, In: Journal of Infectious Diseases. 230, 3, p. 624-634 11 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
Zarowin, D., Coe, J., Bressman, M., Riska, P., Yune, P., Halaseh, G. & Akiyama, M. J., Jun 2024, In: Annals of Internal Medicine Clinical Cases. 3, 6, e231153.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Anorectal Testing for Mpox Virus Infection in Men Who Have Sex with Men with and without Proctitis
Meyerowitz, E. A., Gendlina, I., Desai, V. J., Grossberg, R., Nair, S. R., Pujar, B., Riska, P. F., Root, H. B., Toro, J., Torres, J. A., Pirofski, L. A. & Zingman, B. S., Mar 1 2023, In: Clinical Infectious Diseases. 76, 5, p. 934-937 4 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Posttreatment Lesions After Tecovirimat Treatment for Mpox — New York City, August–September 2022
Seifu, L., Garcia, E., McPherson, T. D., Lash, M., Alroy, K. A., Foote, M., Lee, E. H., Kwong, J., Radix, A., Riska, P., Zucker, J., Zuercher, S. & Wong, M., Apr 28 2023, In: Morbidity and Mortality Weekly Report. 72, 17, p. 471-472 2 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations